Beigene Ltd ADR (BGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BGNE | BMRN | SRPT | ||
| Company | Beigene Ltd ADR | Biomarin Pharmaceuticals | Sarepta Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 162.51 | 84.80 | 132.55 | ||
| High | 162.51 | 84.80 | 133.88 | ||
| Low | 159.26 | 82.79 | 131.16 | ||
| Last | 161.37 | 82.93 | 133.01 | ||
| Change | -0.64 | -0.87 | +2.38 | ||
| % Change | -0.40% | -1.04% | +1.82% | ||
| Volume | 60,201 | 512,852 | 196,790 | ||
| 20-Day Average Volume | 205,437 | 1,926,827 | 869,121 | ||
| Previous Close | 162.01 | 83.80 | 130.63 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 145.65 | 87.54 | 123.87 | ||
| 20-Day Raw Stochastic | 90.77% | 21.93% | 66.19% | ||
| 20-Day Relative Strength | 57.17% | 42.60% | 62.32% | ||
| Weighted Alpha | -31.20 | -13.97 | +21.21 | ||
| Today's Opinion | 40% Sell | 72% Sell | 88% Buy | ||
| Previous Opinion | 40% Sell | 72% Sell | 88% Buy | ||
| Last Month's Opinion | 80% Sell | 64% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.91% since 04/26/24 | +2.98% since 04/26/24 | +3.42% since 04/26/24 | ||
| Low | 150.29 on 04/30/24 | 80.50 on 05/01/24 | 126.53 on 04/30/24 | ||
| High | 164.60 on 05/02/24 | 85.04 on 05/02/24 | 142.79 on 05/02/24 | ||
| 1-Month | |||||
| %Chg | +6.04% since 04/03/24 | -3.99% since 04/03/24 | +4.93% since 04/03/24 | ||
| Low | 126.97 on 04/19/24 | 80.50 on 05/01/24 | 114.37 on 04/19/24 | ||
| High | 164.60 on 05/02/24 | 93.36 on 04/15/24 | 142.79 on 05/02/24 | ||
| 3-Month | |||||
| %Chg | +11.52% since 02/02/24 | -5.44% since 02/02/24 | +9.82% since 02/02/24 | ||
| Low | 126.97 on 04/19/24 | 80.50 on 05/01/24 | 114.37 on 04/19/24 | ||
| High | 184.80 on 03/13/24 | 94.15 on 02/23/24 | 143.00 on 02/16/24 | ||
| 6-Month | |||||
| %Chg | -12.33% since 11/03/23 | +4.69% since 11/03/23 | +70.72% since 11/03/23 | ||
| Low | 126.97 on 04/19/24 | 76.19 on 11/06/23 | 75.85 on 11/09/23 | ||
| High | 205.40 on 11/14/23 | 99.56 on 12/14/23 | 143.00 on 02/16/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 15,494,635 | 15,911,945 | 12,345,318 | ||
| Shares Outstanding, K | 95,640 | 189,880 | 94,506 | ||
| Annual Sales | 2,458,780,000 | 2,419,230,000 | 1,243,340,000 | ||
| Annual Net Income | -881,710,000 | 167,650,000 | -535,980,000 | ||
| Last Quarter Sales | 634,410,000 | 648,830,000 | 396,780,000 | ||
| Last Quarter Net Income | -367,550,000 | 88,660,000 | 45,650,000 | ||
| 60-Month Beta | 0.63 | 0.34 | 0.95 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -3.53 on 02/26/24 | 0.71 on 04/24/24 | 0.73 on 05/01/24 | ||
| Latest Earnings Date | 05/02/24 | 04/24/24 | 05/01/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 61.73 | 1,090.83 | ||